Search

Search Results

• Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure

  Alberto Genovesi Ebert, Furio Colivicchi, Marco Malvezzi Caracciolo, Carmine Riccio

  2016-01-21

  Published: January 21, 2016

  959

  PDF: 617
• 

  Treatment of heart failure with preserved ejection fraction

  Alfredo Monteverde, Valeria Carlino, Giulia Ganci, Giuseppe Taormina, Mario Barbagallo

  2018-06-07

  Published: June 7, 2018

  3423

  PDF: 867
• 

  The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure

  Alberto M. Marra, Andrea Salzano, Michele Arcopinto, Lucrezia Piccioli, Valeria Raparelli

  2018-10-11

  Published: October 11, 2018

  2205

  PDF: 1290

• What underlies NYHA class in elderly patients with heart failure? role of diastolic dysfunction, functional mitral regurgitation and abnormal ventilation during exercise

  Gabriella Malfatto, Paola Cuoccio, Caterina Bizzi, Giovanna Branzi, Alessandra Villani, Francesco Della Rosa, Gianfranco Parati, Mario Facchini

  2016-01-20

  Published: January 20, 2016

  992

  PDF: 708
• 

  Evaluation of left atrial dysfunction by speckle tracking echocardiography in systolic and diastolic heart failure

  Ahmed Ghanaym, Khaled Elkhashab, Gomaa AbdelRazek, Eman Mahmoud

  2022-01-27

  Published: January 27, 2022

  1690

  PDF: 904

• Exercise training for patients with heart failure and preserved ejection fraction. A narrative review

  Giuseppe Caminiti, Maurizio Volterrani, Ferdinando Iellamo, Giuseppe Marazzi, Marco Silvestrini, Domenico Mario Giamundo, Valentina Morsella, Deborah Di Biasio, Alessio Franchini, Marco Alfonso Perrone

  2024-07-23

  Published: July 23, 2024

  882

  PDF_EARLY VIEW: 327

• Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study

  Ombretta Para, Marco Vanetti, Chiara Dibonaventura, Davide Salerno, Lorenzo Caruso, Christian Carleo, Asim Raza, Carlo Nozzoli, Antonio Spanevello

  2025-02-04

  Published: February 4, 2025

  500

  PDF_EARLY VIEW: 169
• 

  Cardiac resynchronization therapy in the elderly. How much is it safe and beneficial?

  Francesco Vetta, Giampaolo Vetta, Sonia Bracchitta, Maria Mignano, Antonella Mattatelli

  2019-03-20

  Published: March 20, 2019

  1614

  PDF: 1059
• 

  Cardiac monitoring during trastuzumab therapy in metastatic breast cancer: early incidence of cardiac dysfunction

  Francesco Perone, Pilar Zamora Auñon, Laura Rodríguez, David Vinal, Juan Caro-Codon, Ana Pertejo, Virginia Martínez Marín, Enrique Espinosa, Teresa López-Fernández

  2022-02-17

  Published: February 17, 2022

  1922

  PDF: 528

• A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise

  Simone Pasquale Crispino, Andrea Segreti, Ylenia La Porta, Paola Liporace, Myriam Carpenito, Valeria Cammalleri, Francesco Grigioni

  2023-03-07

  Published: March 7, 2023

  1292

  PDF: 435
• 

  Difference in prevalence of exertional oscillatory ventilation between healthy subjects and patients with cardiovascular disease

  Ugo Corrà, Massimo Piepoli, Andrea Giordano

  2020-03-27

  Published: March 27, 2020

  1048

  PDF: 604
• 

  Indirect comparison between ferric carboxymaltose and oral iron replacement in heart failure with reduced ejection fraction: a network meta-analysis

  Edoardo Sciatti, Ugo Nesti, Andrea Di Lenarda

  2021-03-31

  Published: March 31, 2021

  5220

  PDF: 1103
• 

  Echocardiography of right ventricular-arterial coupling predicts survival of elderly patients with heart failure and reduced to mid-range ejection fraction

  Gian Marco Rosa, Andreina D'Agostino, Stefano Giovinazzo, Giovanni La Malfa, Paolo Fontanive, Mario Miccoli, Frank Lloyd Dini

  2020-05-15

  Published: May 15, 2020

  1373

  PDF: 758
• 

  TAPSE/PASP use in heart failure: Implementing the evidence for simplicity

  Marco Guazzi

  2020-07-10

  Published: July 10, 2020

  1035

  PDF: 575